DIGIFab

Drug BTG International, Inc.
Total Payments
$24,539
Transactions
129
Doctors
91
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $24,539 129 91

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,563 7 55.3%
Travel and Lodging $7,560 26 30.8%
Food and Beverage $3,013 40 12.3%
Education $403.17 56 1.6%

Top Doctors Receiving Payments for DIGIFab — Page 4

Doctor Specialty Location Total Records
, NP Acute Care Pasadena, CA $7.22 1
, NP Family Moreno Valley, CA $7.22 1
, APRN Family Baton Rouge, LA $7.22 1
, M.D Surgical Critical Care Bartlesville, OK $7.22 1
, MD Emergency Medicine Fort Worth, TX $7.22 1
, DO Family Medicine Sulphur, OK $7.22 1
, MD, MPH Surgical Critical Care Stanford, CA $7.22 1
, M.D Emergency Medicine Los Angeles, CA $7.22 1
, MD Emergency Medicine Torrance, CA $7.22 1
, MD Critical Care Medicine Oklahoma City, OK $7.22 1
, MD Surgery Stanford, CA $7.22 1
, M.D Critical Care Medicine Fullerton, CA $7.22 1
, MD Surgery Stanford, CA $7.22 1
, D.O Internal Medicine Oklahoma City, OK $7.22 1
, MD Emergency Medicine Colton, CA $7.22 1
, M.D Pulmonary Disease Norman, OK $7.22 1

About DIGIFab

DIGIFab is a drug associated with $24,539 in payments to 91 healthcare providers, recorded across 129 transactions in the CMS Open Payments database. The primary manufacturer is BTG International, Inc..

Payment data is available from 2024 to 2024. In 2024, $24,539 was paid across 129 transactions to 91 doctors.

The most common payment nature for DIGIFab is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,563, 55.3% of total).